| AbbVie AG - Relestat, Augentropfen |
| 56310 | | 01 | | Relestat | | Augentropfen | | S01GX10 | | Epinastine | | 07.12.2004 | | |
|
| Composition |
| epinastinum hydrochloridum 0.5 mg, natrii dihydrogenophosphas dihydricus 7.8 mg, natrii chloridum, dinatrii edetas, benzalkonii chloridum 0.1 mg, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Collyre | | | | | | | | | BAG: Principe actif | Concentr. |
|---|
| Epinastini Hydrochloridum | 0.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum aut Natrii Hydroxidum | | | Aqua Purificata | | | Benzalkonium Chlorure | 0.1 mg/ml | | Dinatrii Edetas | | | Epinastine Hydrochloride | 0.5 mg/ml | | Sodium Chlorure | | | Sodium Dihydrogenophosphate Dihydrate | 7.8 mg/ml |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 ml | 7.75 | 17.65 | B | LS | Oui |
|
